Complete revascularization in patients with STEMI and multivessel disease significantly reduced the risk of cardiovascular death or myocardial infarction compared to culprit-lesion-only PCI.
Does complete revascularization with multivessel PCI reduce cardiovascular death or myocardial infarction compared to culprit-lesion-only PCI in patients with STEMI and multivessel coronary artery disease?
In patients with STEMI and multivessel disease, complete revascularization is superior to culprit-lesion-only PCI for reducing the composite of cardiovascular death or myocardial infarction.
Among patients with STEMI and multivessel coronary artery disease, complete revascularization was superior to culprit-lesion-only PCI in reducing the risk of cardiovascular death or myocardial infarction, as well as the risk of cardiovascular death, myocardial infarction, or ischemia-driven revascularization. (Funded by the Canadian Institutes of Health Research and others; COMPLETE ClinicalTrials.gov number, NCT01740479.).
Mehta et al. (2019) studied this question. Complete revascularization in patients with STEMI and multivessel disease significantly reduced the risk of cardiovascular death or myocardial infarction compared to culprit-lesion-only PCI.